Google Glass - now available as shades. Photo: Ajit Niranjan / The New Statesman
Show Hide image

Google Glass launches in the UK, but don't expect to be wearing them anytime soon

Google just launched their prototype smartglasses in the UK, two years after they hit the US.

“Ok, glass.”

Two simple words, and a passable imitation of Benedict Cumberbatch’s public school tones – think Sherlock, not Smaug – start a frenzy of activity in the top right-hand corner of my eye. A list of voice commands appears on a screen that feels as if it's projected eight feet away, which I scroll through with the slightest tilt of my head. 

I triple-tap my temple and suddenly I can see the solar system from within the showroom by Central St. Martins on an overcast Monday evening. Constellations and planets are annotated in space but the text is unnecessary. I turn slowly on the spot till I locate the sun hovering over St. Pancras, and a soft voice reads out a Wikipedia-style entry of the star.

This is Google Glass, the latest in high-tech gadgetry. Star Chart, just one of the apps in the prototype I’m playing about with during Glass’ UK launch last night, is like a virtual planetarium which operates on a point-and-look model – no swiping or clicking needed. GPS and gyroscopes make it perfectly suited to Google’s hands-free headset.

The technology giant is selling the prototype of Google Glass for £1000, but don’t write it off because of the price-tag. Though the final version will undoubtedly be much cheaper, the current model is being released now to get public feedback on the project. Just as it has been in the US, Google is looking for British “Explorers” to test the product out and report their experiences of it. Speaking to The Guardian, 'Head of Glass' Ivy Ross – the intellectual counterpart to Blondie – said:

What you’re seeing now is that the people in businesses that acquired them are coming up with all these amazing use cases for it, but the same thing is happening with consumers – artists, mums, dads, school teachers, scientists – they’re doing amazing things with it too.” 

Their London video gives a little taster of how they expect it to take off.

Set aside the technological jargon – one of the team describes it as an “optical head-mounted display optimised for augmented reality” – and it's hard to deny that Glass is actually quite nifty, and user-friendly too: within ten minutes I've got the hang of interacting with the headset, through a combination of vocal commands, swipes and head nods. The employee demonstrating Glass to me – whose Polish accent is just a touch too strong for the voice recognition software – even showcases the surreptitious "wink-for-a-photo"  command. 

Fun as the applications are, there's a strong mood in the room that Google is onto something bigger than a snazzy gadget. Global director of marketing Ed Sanders believes Glass might help us interact more with the real world by taking us away from smartphones and tablets:

People are looking down; people are getting buried in technology. We have a deep, sort of philosophical desire to help people look back up. And one of the big things behind Glass is how you put people back in the moment.”

Supposedly, its functions can be called up without taking the user away from the action. The demonstrator puts this in perspective: imagine you’re on holiday. Want to find directions to a fancy restaurant? Translate the indecipherable Italian menu? Shazam the Pavarotti in the background? Google thinks Glass will let it embed technology in day-to-day life without detracting from the experiences.

Sanders – who managed to use Glass to record the first time his son said ‘Dada’ – thinks the company really might be onto something. The smartglasses were developed by Google X, a “Charlie-and-the-chocolate-factory” division of Google responsible for projects like the driverless car. The guiding mantra at the semi-secret research facility is to make technology ten times better, not just ten percent – hence the X in the name.

But Glass isn't without its shortcomings. The product's been plagued by bugs and it looks to be a long, long while before a polished, glitch-free version is on the market. Unfortunately the criticisms don't stop there. In the short time I used it, the demonstrator accidentally 'took control' of my glasses by saying commands a bit too loudly. In America it’s come under so much criticism for intruding on privacy that bars and restaurants in tech-hub San Francisco have banned it. Civil liberties groups have voiced concerns that the technology will enable stealthy spying.

Of course, there's the fashion angle as well. Despite partnering up with Ray-Ban and other high-end fashion brands, the fact remains that many users are reluctant to publicise their purchase. Google can make the design as streamlined and versatile as it likes, but something about the mini-computer sat on the bridge of your nose just screams "dweeb". 

So don't expect to see Glass becoming a part of everyday life anytime soon. The technology might be getting there but there's a whole marketing minefield that Google will have to navigate through first. After all, who really wants to be a "Glasshole"?

Getty
Show Hide image

An antibiotic-resistant superbug is silently spreading through UK hospitals

There have already been outbreaks in Manchester, London, Edinburgh, and Birmingham, but deaths are not centrally recorded. 

Lying in a hospital bed, four months pregnant, Emily Morris felt only terror. She had caught a urinary tract infection and it was resistant to common antibiotics. Doctors needed to treat it as it could harm the baby, but the only drugs that could work hadn’t been tested on pregnant women before; the risks were unknown. Overwhelmed, Emily and her husband were asked to make a decision. A few hours later, gripping each other’s arms, they decided she should be given the drugs.

In Emily’s case, the medicine worked and her son Emerson (pictured below with Emily) was born healthy. But rising antibiotic resistance means people are now suffering infections for which there is no cure. Doctors have long warned that decades of reliance on these drugs will lead to a "post-antibiotic era"– a return to time where a scratch could kill and common operations are too risky.

It sounds like hyperbole – but this is already a reality in the UK. In the last four years 25 patients have suffered infections immune to all the antibiotics Public Health England tests for in its central lab, the Bureau of Investigative Journalism has discovered.

While these cases are rare, reports of a highly resistant superbug are rising, and infection control doctors are worried. Carbapenem resistant enterobacteriaceae (CRE) are not only difficult to pronounce, but deadly. These are bugs that live in the human gut but can cause an infection if they get into the wrong place, like the urinary tract or a wound. They have evolved to become immune to most classes of antibiotics – so if someone does become infected, there are only a few drugs that will still work. If CRE bacteria get into the bloodstream, studies show between 40 per cent and 50 per cent of people die.

These bugs are causing huge problems in India, certain parts of Asia, the Middle East and some countries in southern Europe. Until recently, most infections were seen in people who had travelled abroad, had family members who had, or had been in a foreign hospital. The boom in cheap cosmetic surgery in India was blamed for a spate of infections in Britain.

Now, doctors are finding people who have never boarded a plane are carrying the bug. There have already been outbreaks in Manchester, London, Liverpool, Leeds, Edinburgh, Birmingham, Nottingham, Belfast, Dublin and Limerick among other areas. Patients found with CRE have to be treated in side rooms in hospital so the bacteria does not spread and harm other vulnerable patients. But in many of Britain’s Victorian-built hospitals, single rooms are in sparse supply. Deaths from CRE aren’t centrally recorded by the government - but it is thought hundreds have already died. 

Across the country, doctors are being forced to reach for older, more toxic drugs to treat these infections. The amount of colistin – called the "last hope" antibiotic as it is one of few options still effective against CRE infections - rose dramatically in English hospitals between 2014 and 2015, the Bureau has revealed. Colistin was taken off the shelves soon after it was introduced, as it can harm the kidneys and nervous system in high doses, but was reintroduced when infections became immune to standard treatment. The more we use colistin the more bacteria develop resistance to it. It’s only a matter of time before it stops working too, leaving doctors’ arsenal near-empty when it comes to the most dangerous superbug infections.

Due to a kidney problem, Emily Morris suffers repeat urinary tract infections and has to be hospitalised most months. Her son Emerson comes to visit her, understanding his mummy is ill. If she catches a superbug infection, she can still be given intravenous antibiotics to stem it. But she worries about her son. By the time he is an adult, if he gets ill, there may be no drugs left that work.

Madlen Davies is a health and science reporter for the Bureau of Investigative Journalism